131 related articles for article (PubMed ID: 9885436)
1. Biological significance of heterogeneity in human myeloma cells.
Ishikawa H; Kawano MM
Int J Hematol; 1998 Dec; 68(4):363-70. PubMed ID: 9885436
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma.
Ishikawa H; Mahmoud MS; Fujii R; Abroun S; Kawano MM
Leuk Lymphoma; 2000 Sep; 39(1-2):51-5. PubMed ID: 10975383
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells.
Huang N; Kawano MM; Mahmoud MS; Mihara K; Tsujimoto T; Niwa O; Kuramoto A
Blood; 1995 Jun; 85(12):3704-12. PubMed ID: 7780154
[TBL] [Abstract][Full Text] [Related]
4. MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.
Fujii R; Ishikawa H; Mahmoud MS; Asaoku H; Kawano MM
Br J Haematol; 1999 Apr; 105(1):131-40. PubMed ID: 10233376
[TBL] [Abstract][Full Text] [Related]
5. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
Otsuyama K; Asaoku H; Kawano MM
Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
[TBL] [Abstract][Full Text] [Related]
6. Growth mechanism of human myeloma cells by interleukin-6.
Kawano MM; Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X
Int J Hematol; 2002 Aug; 76 Suppl 1():329-33. PubMed ID: 12430875
[TBL] [Abstract][Full Text] [Related]
7. [Myeloma precursor cells].
Iwato K; Kawano MM
Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
[TBL] [Abstract][Full Text] [Related]
8. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
9. [Myeloma precursor cells and their differentiation].
Kawano MM
Nihon Rinsho; 1995 Mar; 53(3):552-6. PubMed ID: 7699884
[TBL] [Abstract][Full Text] [Related]
10. The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells.
Tsuyama N; Ishikawa H; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Taniguchi O; Kawano MM
Hematology; 2003 Dec; 8(6):409-11. PubMed ID: 14668037
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
[TBL] [Abstract][Full Text] [Related]
12. [Phenotypic analysis of myeloma cells].
Mihara K; Harada H; Kawano MM
Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
[TBL] [Abstract][Full Text] [Related]
13. Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cells.
Okikawa Y; Sakai A; Takimoto Y; Noda M; Imagawa J; Katayama Y; Kuroda Y; Okita H; Fujimura K; Kimura A
Int J Hematol; 2004 May; 79(4):364-8. PubMed ID: 15218967
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively.
Kawano MM; Mahmoud MS; Ishikawa H
Br J Haematol; 1997 Oct; 99(1):131-8. PubMed ID: 9359513
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells.
Mihara K
Int J Hematol; 1996 Apr; 63(3):215-26. PubMed ID: 8936335
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells.
Huang N; Kawano MM; Harada H; Harada Y; Sakai A; Kuramoto A; Niwa O
Blood; 1993 Dec; 82(12):3721-9. PubMed ID: 8260709
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules.
Ishikawa H; Tsuyama N; Kawano MM
Int J Hematol; 2003 Aug; 78(2):95-105. PubMed ID: 12953802
[TBL] [Abstract][Full Text] [Related]
19. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]